On Friday, common shares of cannabis stock company, Tetra Bio Pharma Inc. (TSXV:TBP) were delisted from the CSE to move over to TMX Group Ltd.’s (TSX:X) — TSX Ventures Exchange under the same name and trading symbol. Roughly two weeks ago, the move was approved by the TSXV, making Tetra Bio Pharma one of many companies to make the switch.
In March, Invictus MD Strategies Corp. (TSXV:IMH), announced that its common shares would be delisted from the Canadian Securities Exchange (CSE) after the close of trading on March 30, 2017 — and would be uplisted on the TSX Venture Exchange at the open of trading on March 31, 2017.
Moving your listing from the CSE to the TSXV has pros and cons, according to its consulting corporate Lorraine Pike, who had the following to say on CEO Chat:
“The CSE wins in terms of costs and efficiency, while the TSXV remains king in market visibility. As with the other companies that made the move, we expect the corporate executives from Tetra Bio Pharma to ring the TSXV opening bell in the coming days / weeks which will garner additional investor attention. According to some investors we’ve spoken with, their brokerages allow for easier access to TSX and TSXV traded companies than they do for CSE-listed.”
Click here for the entire chat thread here.
Be sure to subscribe to the Growth Stock Network daily newsletter so you never miss a cannabis stock or alternative stock opportunity.